MS News: August 2016

Below are some MS-related topics that made the headlines this month. Do come back to check again, though, as the list will be updated every three days.

Highlight!

1. Guidelines for Neuropsychological Research in Multiple Sclerosis
2. Multiple Sclerosis Journal
3. Johns Hopkins Medicine: Multiple Sclerosis
4. Benign MS
5. Multiple System Atrophy Research
6. $2 Million Grant to Study Fatigue in People with MS
7. What health conditions do people rank as worse than death?
8. Multiple Sclerosis in Children

Research

1. Gut Bacteria and Its Emerging Role in Multiple Sclerosis
2. Multiple Sclerosis May Be Linked to Gastrointestinal Microbiomes
3. Cornell Scientists Tag and Track Lipid Signaling in Cells, a Possible Force in MS Development
4. Brain Inflammation Linked to Depression in Multiple Sclerosis
5. A study of patients with aggressive multiple sclerosis at disease onset
6. Monoclonal Antibody Shows Promise as Multiple Sclerosis Treatment
7. Researchers develop technology for treating multiple sclerosis with gaming cameras
8. Microsoft Kinect may help in treating multiple sclerosis patients: Study
9. For Proper Diagnosis and Treatment of MS, Time is of the Essence
10. Treating at the Earliest Sign of MS May Offer Long-Term Benefit
11. Early Treatment and the Transition From Clinically Isolated Syndrome to MS
12. The Relationship between Gray Matter Quantitative MRI and Disability in Secondary Progressive Multiple Sclerosis
13. Brain Inflammation Countered by Neuronal Growth in Mouse Model of MS

Clinical Trials

1. Oral Multiple Sclerosis Drug Completes Phase 2 Trial
2. Cholesterol Drugs May Slow Multiple Sclerosis
3. Natalizumab Affects T-Cell Phenotype in Multiple Sclerosis
4. Genentech Enrolling Relapsing MS Patients in Study of Mechanism of Action for Ocrevus
5. RedHill Biopharma Announces Last Patient Visit in Phase IIa Study with RHB-104 for Multiple …
6. Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes
7. Tysabri’s Success in Impairing the Immune System in RRMS May Be Source of Its Problems

Treatment News

1. Neurologists Report Increasing Payer Pressure For Disease-Modifying Therapies, Resulting In …
2. Multiple Sclerosis Patients Stressed Out By Soaring Drug Costs
3. Drug companies offer ‘money back guarantees’ to make cutting-edge therapies more attractive
4. Multiple sclerosis: thrice weekly glatiramer acetate efficacy sustained in 3-year trial
5. Researchers Discover Mechanism of Action in MS Therapy Tecfidera
6. Antioxidant therapies may help in the fight against neurodegenerative diseases
7. Drug companies offer ‘money back guarantees’ to make cutting-edge therapies more attractive
8. The impact of drugs for multiple sclerosis on sleep
9. What is the Solu-Medrol Journey in MS?

Stem Cell Treatment

1. New Pre-HSCT Treatment May Make Stem Cell Transplants a Safer Option for MS Patients

News posted on Barts MS Blog

1. PoliticalSpeak: Big Pharma in the Dog House
2. BrainHealth & ClinicSpeak: a brain health guide for people with MS
3. Visual loss due to acute retinal necrosis on natalizumab
4. Long term follow up of beta interferon use
5. Survey Results & Wound Healing

Mental Health

1. Improving Confidence of RRMS Patients May Enhance Quality of Life, Decrease Depression, Study …

Diet

1. Pilot Study Finds Fatigue, Mood in MS Patients Improved by Low-Fat, Plant-Based Diet
2. Low-Fat, Plant-Based Diet for MS Patients: Many Benefits, but No MRI Improvements

Exercise

Lifestyle

1. Successive Pregnancies Not Associated With MS Relapse Rate
2. Multiple Sclerosis and Pregnancy
3. Guest actor stole $60G from former ‘Criminal Minds’ star Shemar Moore
4. The Multiple Sclerosis Association of America Launches Online Support Community for Individuals …

When You’ve Just Been Diagnosed or New Symptoms Visit You

1. 5 Things a Neurologist Wants You to Know About Multiple Sclerosis
2. MSAA Opens New Online Community Forum for MS Patients, Caregivers

3. Why Do I Startle So Easily and Sounds Are Too Loud?

Business News

1. Teva Q2 results boosted by rising Copaxone sales
2. Multiple Sclerosis Drugs Market and R&D Outlook 2016-2026
3. With Allergan deal sealed, Teva turns its attention to branded M&A
4. Pharmalot, Pharmalittle: Biogen is the latest pharma takeover target
5. New Orleans biotech firm gets $455000 in research grants
6. Medical Affairs Reputation: Multiple Sclerosis (EU5)

Videos

1. Neuropathology and Diagnosis of Multiple Sclerosis
2. Innovations in Diagnosis and Treatment of Multiple Sclerosis
3. NAELA Releases Video Series for People With Multiple Sclerosis

____________________________________________________________________________________________
© Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2016. Unauthorised use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.